Latest filing published 20 Nov 2023 for Acura Pharmaceuticals, INC.
No signal scores available.
Albert W. Brzeczko is a declared insider of Acura Pharmaceuticals, Inc, with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 3 August 2022 and the latest from 20 November 2023.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 20 November 2023: an option exercise, in Acura Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations